ReCode Therapeutics Competitors and Similar CompaniesClear all
BillionToOne's competitors and similar companies include Verona Pharma.
 BillionToOne BillionToOne is a precision diagnostics company offering prenatal cystic fibrosis and spinal muscular atrophy screening options. |  Verona Pharma Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases. | |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Menlo Park, US HQ | Locations London, GB HQ Cardiff, GB Raleigh, US |
Employees | Employees 620 | Employees 79 |
Financial | ||
Revenue (est.) | Revenue (est.) $305.1m (FY, 2025) | Revenue (est.) $42.3m (FY, 2024) |
Cost of goods | Cost of goods $96.7m (FY, 2025) | Cost of goods $1.4m (FY, 2024) |
Gross profit | Gross profit $208.5m (FY, 2025) | Gross profit $40.9m (FY, 2024) |
Net income | Net income $7.5m (FY, 2025) | Net income ($173.2m) (FY, 2024) |
Funding | ||
Total funding raised | Total funding raised $ 87.5m | Total funding raised $ 11.5m |
For sources of this data, please see the company profile
View Company Profiles
Verona Pharma
HQ
London, GB
Employees
79
Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases.
View company